Cargando…
Prevalence of low bone formation in untreated patients with osteoporosis
BACKGROUND: Osteoporosis treatment usually starts with an antiresorber and switches to an anabolic agent if it fails. It is known that suppressing bone resorption also results in reduced bone formation. In addition, patients with prior treatment with antiresorbers may have reduced response to subseq...
Autores principales: | Malluche, Hartmut H., Davenport, Daniel L., Lima, Florence, Monier-Faugere, Marie-Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295966/ https://www.ncbi.nlm.nih.gov/pubmed/35853025 http://dx.doi.org/10.1371/journal.pone.0271555 |
Ejemplares similares
-
Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
por: Malluche, Hartmut H, et al.
Publicado: (2021) -
Diagnosis of low bone mass in CKD-5D patients
por: Blomquist, Gustav A., et al.
Publicado: (2016) -
FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023) -
Response to “Low Turnover Bone Disease in Early CKD Stages”
por: El-Husseini, Amr, et al.
Publicado: (2022) -
FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis
por: Lima, Florence, et al.
Publicado: (2014)